Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HemosIL Factor V Leiden (APC Resistance V)

K-Number: K260551 · 2026-03-20

Decision Date2026-03-20
Product CodeGGW
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HemosIL Factor V Leiden (APC Resistance V) is a medical device manufactured by Instrumentation Laboratory (IL) Co.. It received FDA 510(k) clearance on 2026-03-20 under approval number K260551. The device is classified under product code GGW. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HemosIL Factor V Leiden (APC Resistance V)?

HemosIL Factor V Leiden (APC Resistance V) is a medical device that received FDA 510(k) clearance on 2026-03-20. It is manufactured by Instrumentation Laboratory (IL) Co.. The 510(k) number is K260551.

When was HemosIL Factor V Leiden (APC Resistance V) approved by the FDA?

HemosIL Factor V Leiden (APC Resistance V) received FDA 510(k) clearance on 2026-03-20, under approval number K260551.

What company makes HemosIL Factor V Leiden (APC Resistance V)?

HemosIL Factor V Leiden (APC Resistance V) is manufactured by Instrumentation Laboratory (IL) Co..

What is the FDA product code for HemosIL Factor V Leiden (APC Resistance V)?

The FDA product code for HemosIL Factor V Leiden (APC Resistance V) is GGW.

Related Clinical Trials

Other Devices by Instrumentation Laboratory (IL) Co.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.